{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:27:02Z","timestamp":1793298422590,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T00:00:00Z","timestamp":1626739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T00:00:00Z","timestamp":1626739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472305"],"award-info":[{"award-number":["81472305"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Renal cell carcinoma (RCC) cells have increased lipogenesis and cholesterol synthesis. Sterol regulatory element-binding protein-1 (SREBP1) is cleaved by site 1 protease (S1P) to release the transcriptionally active amino-terminal domain. PF-429242 is a potent and competitive S1P inhibitor. We here tested its activity in RCC cells. In established and primary human RCC cells, PF-429242 potently inhibited cell proliferation, migration, and invasion. The S1P inhibitor provoked apoptosis activation in RCC cells. Furthermore, shRNA-mediated S1P silencing or CRISPR\/Cas9-induced S1P knockout led to RCC cell growth inhibition and apoptosis activation. Conversely, ectopic overexpression of SREBP1 or S1P augmented RCC cell proliferation and migration. Daily <jats:italic>i.v<\/jats:italic>. injection of a single dose of PF-429242 robustly inhibited RCC xenograft growth in severe combined immunodeficiency mice. Additionally, intratumoral injection of S1P shRNA lentivirus inhibited RCC xenograft growth in mice. SREBP1, S1P, and its target gene low density lipoprotein receptor (LDLR) were significantly elevated in human RCC tissues. These results suggest that targeting S1P by PF-429242 inhibited RCC cell growth in vitro and in vivo.<\/jats:p>","DOI":"10.1038\/s41419-021-03999-9","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T06:02:56Z","timestamp":1626760976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["SREBP1 site 1 protease inhibitor PF-429242 suppresses renal cell carcinoma cell growth"],"prefix":"10.1038","volume":"12","author":[{"given":"Tong-bing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-guo","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu-zheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0913-860X","authenticated-orcid":false,"given":"Bin-hai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7003-9555","authenticated-orcid":false,"given":"Qiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,20]]},"reference":[{"key":"3999_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7\u201330.","journal-title":"CA Cancer J Clin."},{"key":"3999_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7\u201334.","journal-title":"CA Cancer J Clin."},{"key":"3999_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nature12222","volume":"499","author":"Cancer Genome Atlas Research, Network.","year":"2013","unstructured":"Cancer Genome Atlas Research, Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013;499:43\u201349.","journal-title":"Nature."},{"key":"3999_CR4","doi-asserted-by":"publisher","first-page":"857","DOI":"10.2174\/156800912802429265","volume":"12","author":"Z Mihaly","year":"2012","unstructured":"Mihaly Z, Sztupinszki Z, Surowiak P, Gyorffy B. A comprehensive overview of targeted therapy in metastatic renal cell carcinoma. Curr Cancer Drug Targets. 2012;12:857\u201372.","journal-title":"Curr Cancer Drug Targets."},{"key":"3999_CR5","first-page":"S60","volume":"16","author":"A Kapoor","year":"2009","unstructured":"Kapoor A, Gharajeh A, Sheikh A, Pinthus J. Adjuvant and neoadjuvant small-molecule targeted therapy in high-risk renal cell carcinoma. Curr Oncol. 2009;16:S60\u201366.","journal-title":"Curr Oncol."},{"key":"3999_CR6","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.eururo.2012.02.039","volume":"61","author":"S MacLennan","year":"2012","unstructured":"MacLennan S, Imamura M, Lapitan MC, Omar MI, Lam TB, Hilvano-Cabungcal AM, et al. Systematic review of oncological outcomes following surgical management of localised renal cancer. Eur Urol. 2012;61:972\u201393.","journal-title":"Eur Urol."},{"key":"3999_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/bjc.1996.326","volume":"74","author":"B Ljungberg","year":"1996","unstructured":"Ljungberg B, Mehle C, Stenling R, Roos G. Heterogeneity in renal cell carcinoma and its impact no prognosis-a flow cytometric study. Br J Cancer. 1996;74:123\u20137.","journal-title":"Br J Cancer"},{"key":"3999_CR8","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1089\/cmb.2019.0145","volume":"26","author":"F Li","year":"2019","unstructured":"Li F, Guo P, Dong K, Guo P, Wang H, Lv X. Identification of key biomarkers and potential molecular mechanisms in renal cell carcinoma by bioinformatics analysis. J Comput Biol. 2019;26:1278\u201395.","journal-title":"J Comput Biol."},{"key":"3999_CR9","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/nrurol.2013.52","volume":"10","author":"HI Wettersten","year":"2013","unstructured":"Wettersten HI, Weiss RH. Potential biofluid markers and treatment targets for renal cell carcinoma. Nat Rev Urol. 2013;10:336\u201344.","journal-title":"Nat Rev Urol."},{"key":"3999_CR10","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.eururo.2010.06.032","volume":"58","author":"B Ljungberg","year":"2010","unstructured":"Ljungberg B, Cowan NC, Hanbury DC, Hora M, Kuczyk MA, Merseburger AS, et al. EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol. 2010;58:398\u2013406.","journal-title":"Eur Urol."},{"key":"3999_CR11","doi-asserted-by":"crossref","unstructured":"Lee, JH, Jeon, YG, Lee, KH, Lee, HW, Park, J, Jang, H, et al. RNF20 suppresses tumorigenesis by inhibiting the SREBP1c-PTTG1 axis in kidney cancer. Mol Cell Biol. 2017;37:e00265-17.","DOI":"10.1128\/MCB.00265-17"},{"key":"3999_CR12","doi-asserted-by":"crossref","unstructured":"Sethi, G, Shanmugam, MK & Kumar, AP. SREBP-1c as a molecular bridge between lipogenesis and cell cycle progression of clear cell renal carcinoma. Biosci Rep.2017;37:BSR20171270.","DOI":"10.1042\/BSR20171270"},{"key":"3999_CR13","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/nrendo.2017.91","volume":"13","author":"H Shimano","year":"2017","unstructured":"Shimano H, Sato R. SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology. Nat Rev Endocrinol.2017;13:710\u201330.","journal-title":"Nat Rev Endocrinol."},{"key":"3999_CR14","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.biochi.2004.09.018","volume":"86","author":"D Eberle","year":"2004","unstructured":"Eberle D, Hegarty B, Bossard P, Ferre P, Foufelle F. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie. 2004;86:839\u201348.","journal-title":"Biochimie."},{"key":"3999_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0092-8674(94)90234-8","volume":"77","author":"X Wang","year":"1994","unstructured":"Wang X, Sato R, Brown MS, Hua X, Goldstein JL. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell. 1994;77:53\u201362.","journal-title":"Cell."},{"key":"3999_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0092-8674(05)80095-9","volume":"75","author":"C Yokoyama","year":"1993","unstructured":"Yokoyama C, Wang X, Briggs MR, Admon A, Wu J, Hua X, et al. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell. 1993;75:187\u201397.","journal-title":"Cell."},{"key":"3999_CR17","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.2174\/13816128113199990486","volume":"20","author":"D Guo","year":"2014","unstructured":"Guo D, Bell EH, Mischel P, Chakravarti A. Targeting SREBP-1-driven lipid metabolism to treat cancer. Curr Pharm Des. 2014;20:2619\u201326.","journal-title":"Curr Pharm Des."},{"key":"3999_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.antiviral.2014.12.017","volume":"115","author":"M Blanchet","year":"2015","unstructured":"Blanchet M, Sureau C, Guevin C, Seidah NG, Labonte P. SKI-1\/S1P inhibitor PF-429242 impairs the onset of HCV infection. Antivir. Res. 2015;115:94\u2013104.","journal-title":"Antivir. Res"},{"key":"3999_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.virol.2011.11.008","volume":"423","author":"A Pasquato","year":"2012","unstructured":"Pasquato A, Rochat C, Burri DJ, Pasqual G, de la Torre JC, Kunz S. Evaluation of the anti-arenaviral activity of the subtilisin kexin isozyme-1\/site-1 protease inhibitor PF-429242. Virology 2012;423:14\u201322.","journal-title":"Virology"},{"key":"3999_CR20","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1159\/000485582","volume":"44","author":"CM Chen","year":"2017","unstructured":"Chen CM, Hsieh SC, Lin CL, Lin YS, Tsai JP, Hsieh YH. Alpha-mangostin suppresses the metastasis of human renal carcinoma cells by targeting MEK\/ERK expression and MMP-9 transcription activity. Cell Physiol Biochem. 2017;44:1460\u201370.","journal-title":"Cell Physiol Biochem"},{"key":"3999_CR21","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1159\/000472407","volume":"41","author":"X Wu","year":"2017","unstructured":"Wu X, Liu D, Gao X, Xie F, Tao D, Xiao X, et al. Inhibition of BRD4 Suppresses Cell Proliferation and Induces Apoptosis in Renal Cell Carcinoma. Cell Physiol Biochem. 2017;41:1947\u201356.","journal-title":"Cell Physiol Biochem."},{"key":"3999_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2566-1","volume":"11","author":"M Xu","year":"2020","unstructured":"Xu M, Wang Y, Zhou LN, Xu LJ, Jin ZC, Yang DR, et al. The therapeutic value of SC66 in human renal cell carcinoma cells. Cell Death Dis. 2020;11:353.","journal-title":"Cell Death Dis."},{"key":"3999_CR23","doi-asserted-by":"publisher","first-page":"98471","DOI":"10.18632\/oncotarget.21432","volume":"8","author":"H Zhu","year":"2017","unstructured":"Zhu H, Mao JH, Wang Y, Gu DH, Pan XD, Shan Y, et al. Dual inhibition of BRD4 and PI3K-AKT by SF2523 suppresses human renal cell carcinoma cell growth. Oncotarget. 2017;8:98471\u201381.","journal-title":"Oncotarget."},{"key":"3999_CR24","doi-asserted-by":"publisher","first-page":"e0172555","DOI":"10.1371\/journal.pone.0172555","volume":"12","author":"XD Pan","year":"2017","unstructured":"Pan XD, Gu DH, Mao JH, Zhu H, Chen X, Zheng B, et al. Concurrent inhibition of mTORC1 and mTORC2 by WYE-687 inhibits renal cell carcinoma cell growth in vitro and in vivo. PLoS One. 2017;12:e0172555.","journal-title":"PLoS One"},{"key":"3999_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.canlet.2018.11.028","volume":"443","author":"SS Wang","year":"2019","unstructured":"Wang SS, Lv Y, Xu XC, Zuo Y, Song Y, Wu GP, et al. Triptonide inhibits human nasopharyngeal carcinoma cell growth via disrupting Lnc-RNA THOR-IGF2BP1 signaling. Cancer Lett. 2019;443:13\u201324.","journal-title":"Cancer Lett."},{"key":"3999_CR26","doi-asserted-by":"publisher","first-page":"52699","DOI":"10.18632\/oncotarget.17084","volume":"8","author":"Y Lv","year":"2017","unstructured":"Lv Y, Si M, Chen N, Li Y, Ma X, Yang H, et al. TBX2 over-expression promotes nasopharyngeal cancer cell proliferation and invasion. Oncotarget.2017;8:52699\u2013707.","journal-title":"Oncotarget."},{"key":"3999_CR27","doi-asserted-by":"publisher","first-page":"4342","DOI":"10.7150\/thno.34090","volume":"9","author":"S Wang","year":"2019","unstructured":"Wang S, Zhong L, Li Y, Xiao D, Zhang R, Liao D, et al. Up-regulation of PCOLCE by TWIST1 promotes metastasis in Osteosarcoma. Theranostics. 2019;9:4342\u201353.","journal-title":"Theranostics."},{"key":"3999_CR28","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.canlet.2014.11.012","volume":"357","author":"B Zheng","year":"2015","unstructured":"Zheng B, Mao JH, Qian L, Zhu H, Gu DH, Pan XD, et al. Pre-clinical evaluation of AZD-2014, a novel mTORC1\/2 dual inhibitor, against renal cell carcinoma. Cancer Lett. 2015;357:468\u201375.","journal-title":"Cancer Lett."},{"key":"3999_CR29","doi-asserted-by":"publisher","first-page":"9489","DOI":"10.18632\/aging.103221","volume":"12","author":"X Ye","year":"2020","unstructured":"Ye X, Ruan JW, Huang H, Huang WP, Zhang Y, Zhang F. PI3K-Akt-mTOR inhibition by GNE-477 inhibits renal cell carcinoma cell growth in vitro and in vivo. Aging. 2020;12:9489\u201399.","journal-title":"Aging."},{"key":"3999_CR30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.canlet.2020.02.018","volume":"476","author":"J Zheng","year":"2020","unstructured":"Zheng J, Zhang Y, Cai S, Dong L, Hu X, Chen MB, et al. MicroRNA-4651 targets bromodomain-containing protein 4 to inhibit non-small cell lung cancer cell progression. Cancer Lett. 2020;476:129\u201339.","journal-title":"Cancer Lett."},{"key":"3999_CR31","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.bbrc.2019.06.056","volume":"516","author":"XF Chen","year":"2019","unstructured":"Chen XF, Pan YS, Zheng B, Lu Q. p38gamma overexpression promotes renal cell carcinoma cell growth, proliferation and migration. Biochem Biophys Res Commun. 2019;516:466\u201373.","journal-title":"Biochem Biophys Res Commun."},{"key":"3999_CR32","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.freeradbiomed.2019.08.024","volume":"143","author":"XZ Xu","year":"2019","unstructured":"Xu XZ, Tang Y, Cheng LB, Yao J, Jiang Q, Li KR, et al. Targeting Keap1 by miR-626 protects retinal pigment epithelium cells from oxidative injury by activating Nrf2 signaling. Free Radic Biol Med. 2019;143:387\u201396.","journal-title":"Free Radic Biol Med."},{"key":"3999_CR33","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/fphar.2020.00265","volume":"11","author":"D Dorotea","year":"2020","unstructured":"Dorotea D, Koya D, Ha H. Recent insights into SREBP as a direct mediator of kidney fibrosis via lipid-independent pathways. Front Pharm. 2020;11:265.","journal-title":"Front Pharm."},{"key":"3999_CR34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/ki.1994.6","volume":"45","author":"MJ Ryan","year":"1994","unstructured":"Ryan MJ, Johnson G, Kirk J, Fuerstenberg SM, Zager RA, Torok-Storb B. HK-2: an immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int. 1994;45:48\u201357.","journal-title":"Kidney Int"},{"key":"3999_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00204-011-0742-x","volume":"86","author":"Y Komoike","year":"2012","unstructured":"Komoike Y, Inamura H, Matsuoka M. Effects of salubrinal on cadmium-induced apoptosis in HK-2 human renal proximal tubular cells. Arch Toxicol. 2012;86:37\u201344.","journal-title":"Arch Toxicol."},{"key":"3999_CR36","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1365-2184.2012.00814.x","volume":"45","author":"X Wen","year":"2012","unstructured":"Wen X, Lin ZQ, Liu B, Wei YQ. Caspase-mediated programmed cell death pathways as potential therapeutic targets in cancer. Cell Prolif. 2012;45:217\u201324.","journal-title":"Cell Prolif."},{"key":"3999_CR37","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1023\/A:1016167228059","volume":"7","author":"M Chen","year":"2002","unstructured":"Chen M, Wang J. Initiator caspases in apoptosis signaling pathways. Apoptosis. 2002;7:313\u20139.","journal-title":"Apoptosis."},{"key":"3999_CR38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/sj.cdd.4400476","volume":"6","author":"AG Porter","year":"1999","unstructured":"Porter AG, Janicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 1999;6:99\u2013104.","journal-title":"Cell Death Differ."},{"key":"3999_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4128","volume":"5","author":"R Nilsson","year":"2014","unstructured":"Nilsson R, Jain M, Madhusudhan N, Sheppard NG, Strittmatter L, Kampf C, et al. Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer. Nat Commun. 2014;5:3128.","journal-title":"Nat Commun."},{"key":"3999_CR40","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/sj.bjc.6604554","volume":"99","author":"ED Michelakis","year":"2008","unstructured":"Michelakis ED, Webster L, Mackey JR. Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer. Br J Cancer. 2008;99:989\u201394.","journal-title":"Br J Cancer"},{"key":"3999_CR41","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.trecan.2017.10.006","volume":"3","author":"PJ Burke","year":"2017","unstructured":"Burke PJ. Mitochondria, bioenergetics and apoptosis in. Cancer Trends Cancer 2017;3:857\u201370.","journal-title":"Cancer Trends Cancer"},{"key":"3999_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5904-x","volume":"19","author":"Y Gao","year":"2019","unstructured":"Gao Y, Nan X, Shi X, Mu X, Liu B, Zhu H, et al. SREBP1 promotes the invasion of colorectal cancer accompanied upregulation of MMP7 expression and NF-kappaB pathway activation. BMC Cancer. 2019;19:685.","journal-title":"BMC Cancer"},{"key":"3999_CR43","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1080\/21655979.2019.1676485","volume":"10","author":"W Shen","year":"2019","unstructured":"Shen W, Xu T, Chen D, Tan X. Targeting SREBP1 chemosensitizes colorectal cancer cells to gemcitabine by caspase-7 upregulation. Bioengineered 2019;10:459\u201368.","journal-title":"Bioengineered"},{"key":"3999_CR44","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s13046-019-1288-7","volume":"38","author":"C Zhou","year":"2019","unstructured":"Zhou C, Qian W, Li J, Ma J, Chen X, Jiang Z, et al. High glucose microenvironment accelerates tumor growth via SREBP1-autophagy axis in pancreatic cancer. J Exp Clin Cancer Res. 2019;38:302.","journal-title":"J Exp Clin Cancer Res."},{"key":"3999_CR45","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41418-018-0158-8","volume":"26","author":"N Zhang","year":"2019","unstructured":"Zhang N, Zhang H, Liu Y, Su P, Zhang J, Wang X, et al. SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1\/2. Cell Death Differ. 2019;26:843\u201359.","journal-title":"Cell Death Differ."},{"key":"3999_CR46","doi-asserted-by":"crossref","unstructured":"Huang, CM, Huang, CS, Hsu, TN, Huang, MS, Fong, IH, Lee, WH, et al. Disruption of cancer metabolic SREBP1\/miR-142-5p suppresses Epithelial-Mesenchymal transition and stemness in esophageal carcinoma. Cells. 2019;9:7.","DOI":"10.3390\/cells9010007"},{"key":"3999_CR47","doi-asserted-by":"crossref","unstructured":"Uchida, L, Urata, S, Ulanday, GE, Takamatsu, Y, Yasuda, J, Morita, K, et al. Suppressive Effects of the Site 1 Protease (S1P) Inhibitor, PF-429242, on Dengue Virus Propagation. Viruses. 2016;8:46.","DOI":"10.3390\/v8020046"},{"key":"3999_CR48","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3892\/mco.2014.478","volume":"3","author":"C Wei","year":"2015","unstructured":"Wei C, Yang X, Xi J, Wu W, Yang Z, Wang W, et al. High expression of pituitary tumor-transforming gene-1 predicts poor prognosis in clear cell renal cell carcinoma. Mol Clin Oncol. 2015;3:387\u201391.","journal-title":"Mol Clin Oncol."},{"key":"3999_CR49","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.1158\/0008-5472.CAN-11-2330","volume":"72","author":"B Wondergem","year":"2012","unstructured":"Wondergem B, Zhang Z, Huang D, Ong CK, Koeman J, Hof DV, et al. Expression of the PTTG1 oncogene is associated with aggressive clear cell renal cell carcinoma. Cancer Res. 2012;72:4361\u201371.","journal-title":"Cancer Res"},{"key":"3999_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-4-3","volume":"4","author":"T Hamid","year":"2005","unstructured":"Hamid T, Malik MT, Kakar SS. Ectopic expression of PTTG1\/securin promotes tumorigenesis in human embryonic kidney cells. Mol Cancer. 2005;4:3.","journal-title":"Mol Cancer"},{"key":"3999_CR51","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1159\/000487293","volume":"45","author":"L Yao","year":"2018","unstructured":"Yao L, Guo X, Gui Y. Acetyl-CoA synthetase 2 promotes cell migration and invasion of renal cell carcinoma by upregulating Lysosomal-associated membrane protein 1 expression. Cell Physiol Biochem. 2018;45:984\u201392.","journal-title":"Cell Physiol Biochem"},{"key":"3999_CR52","doi-asserted-by":"publisher","first-page":"243.e249","DOI":"10.1016\/j.urolonc.2018.01.013","volume":"36","author":"S Zhang","year":"2018","unstructured":"Zhang S, He J, Jia Z, Yan Z, Yang J. Acetyl-CoA synthetase 2 enhances tumorigenesis and is indicative of a poor prognosis for patients with renal cell carcinoma. Urol Oncol. 2018;36:243.e249\u20133.e20.","journal-title":"Urol Oncol."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03999-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03999-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03999-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T09:08:21Z","timestamp":1669972101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03999-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,20]]},"references-count":52,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["3999"],"URL":"https:\/\/doi.org\/10.1038\/s41419-021-03999-9","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,20]]},"assertion":[{"value":"17 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Jiangsu University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Statement"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"COMPETING INTERESTS"}}],"article-number":"717"}}